About us

Pelago Bioscience was founded in 2013 with the aim to develop the patented Cellular Thermal Shift Assay (CETSA®) for maximum utility and customer value in drug discovery and diagnostics. Today, we deliver in situ target engagement studies to accelerate preclinical and clinical drug discovery and development to a world-wide customer base. Using CETSA® data and applications, our customers are able to make better and more informed decisions at earlier stages in their projects. Our scientific team are the experts in both targeted CETSA® using antibodies for the detection and proteome-wide mass spectrometry-based CETSA® applications, find out more on the Pelago services page

The Pelago Bioscience Team

Veerle Paternoster

Senior Scientist

Tove Boström

Senior Scientist

Tomas Friman

Senior Scientist

Stina Lundgren

Head of Commercial Operations

Sean Tyacke

CCO

Sarah Sandoz

Operations Manager

Rikard Alm

Senior Scientist

Renato Alves

Project Advisor

Michael Dabrowski

CEO

Marie Karlsson

Scientist

Johan Karlsson

Finance Manager

Jakub Lewicki

Key Account Manager